Symptoms and Otorhinolaryngological Sequalae in Long Covid
- PMID: 40470173
- PMCID: PMC12133385
- DOI: 10.1055/s-0045-1809026
Symptoms and Otorhinolaryngological Sequalae in Long Covid
Abstract
Introduction: After the pandemic caused by the coronavirus, many patients have presented remaining otorhinolaryngological symptoms, but most of them are unknown to health professionals.
Objectives: To characterize otorhinolaryngological symptoms and sequelae in hospitalized patients for Covid-19.
Methods: We made a recall to patients hospitalized between April 2020 and April 2022 due to Covid-19. Demographic data, initial and remaining symptoms, days of hospitalization, intubation and/or tracheostomy, and vaccination data were collected.
Results: 845 patients were hospitalized, 441 died, 404 patients were contacted by telephone, but only 109 responded to the questionnaire about initial and remaining otorhinolaryngological symptoms after 1.5 to 2 years of illness, 59 men and 50 women, with an average age of 58.61 years (20 to 94). Two study groups were composed: G 1 (n- 44; with remaining symptoms) and G 2 (n- 65; without remaining symptoms). 81% of patients in G1 and 67% of patients in G2 had been hospitalized for up to 20 days. Intubation occurred in 17 patients (G1-7; G2-10). Seven patients underwent tracheostomy. The most prevalent initial and remaining otorhinolaryngological symptoms, respectively, were dyspnea (68.8%; 14.6%), cough (65.1%; 11.92%), nasal obstruction (47.7%; 5.58%), smell dysfunction (44%; 11%), taste dysfunction (42%; 4.58%). Vaccination was reported by 54 patients (G1-21; G2-34).
Conclusions: Otorhinolaryngological symptoms were common in patients hospitalized for Covid-19, especially dyspnea, cough, nasal obstruction, smell, and taste dysfunction. Although there was a favorable long-term evolution, 40% of patients maintained permanent symptoms, such as smell and taste dysfunction and dizziness, unrelated to the vaccine doses.
Keywords: long covid; otorhinolaryngological sequelae; otorhinolaryngological symptoms.
The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit ( https://creativecommons.org/licenses/by/4.0/ ).
Conflict of interest statement
Conflict of Interest None.
Figures
Similar articles
-
A structural equation model to examine the clinical features of mild-to-moderate COVID-19: A multicenter Italian study.J Med Virol. 2021 Feb;93(2):983-994. doi: 10.1002/jmv.26354. Epub 2020 Aug 2. J Med Virol. 2021. PMID: 32710639
-
The clinical course of smell and taste loss in COVID-19 hospitalized patients.Hippokratia. 2020 Apr-Jun;24(2):66-71. Hippokratia. 2020. PMID: 33488054 Free PMC article.
-
Olfactory and Gustatory Dysfunctions as a Clinical Manifestation of Coronavirus Disease 2019 in a Malaysian Tertiary Center.Ann Otol Rhinol Laryngol. 2021 May;130(5):513-519. doi: 10.1177/0003489420963165. Epub 2020 Oct 7. Ann Otol Rhinol Laryngol. 2021. PMID: 33025798
-
Persistent ENT Manifestations in Individuals who Recovered from COVID-19: A Systematic Review.Int Arch Otorhinolaryngol. 2024 Mar 15;28(4):e697-e701. doi: 10.1055/s-0043-1777805. eCollection 2024 Oct. Int Arch Otorhinolaryngol. 2024. PMID: 39464351 Free PMC article. Review.
-
Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis with parametric cure modelling of recovery curves.BMJ. 2022 Jul 27;378:e069503. doi: 10.1136/bmj-2021-069503. BMJ. 2022. PMID: 35896188 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Miscellaneous